Archives

  • 2026-05
  • 2026-04
  • 2026-03
  • 2026-02
  • 2026-01
  • 2025-12
  • 2025-11
  • 2025-10
  • 2025-09
  • 2025-04
  • 2025-03
  • 2025-02
  • 2025-01
  • 2024-12
  • 2024-11
  • 2024-10
  • 2024-09
  • 2024-08
  • 2024-07
  • 2024-06
  • 2024-05
  • 2024-04
  • 2024-03
  • 2024-02
  • 2024-01
  • 2023-12
  • 2023-11
  • 2023-10
  • 2023-09
  • 2023-08
  • 2023-06
  • 2023-05
  • 2023-04
  • 2023-03
  • 2023-02
  • 2023-01
  • 2022-12
  • 2022-11
  • 2022-10
  • 2022-09
  • 2022-08
  • 2022-07
  • 2022-06
  • 2022-05
  • 2022-04
  • 2022-03
  • 2022-02
  • 2022-01
  • 2021-12
  • 2021-11
  • 2021-10
  • 2021-09
  • 2021-08
  • 2021-07
  • 2021-06
  • 2021-05
  • 2021-04
  • 2021-03
  • 2021-02
  • 2021-01
  • 2020-12
  • 2020-11
  • 2020-10
  • 2020-09
  • 2020-08
  • 2020-07
  • 2020-06
  • 2020-05
  • 2020-04
  • 2020-03
  • 2020-02
  • 2020-01
  • 2019-12
  • 2019-11
  • 2019-10
  • 2019-09
  • 2019-08
  • 2019-07
  • 2019-06
  • 2019-05
  • 2019-04
  • 2018-07
  • Dantrolene, sodium salt: A Benchmark Ryanodine Receptor A...

    2026-03-20

    Dantrolene, sodium salt: A Benchmark Ryanodine Receptor Antagonist for Calcium Signaling and Genome Editing Research

    Executive Summary: Dantrolene sodium salt is a highly selective ryanodine receptor (RyR) antagonist with an IC50 of 5.9 ± 0.3 nM for RyR2, enabling precise modulation of intracellular calcium release (APExBIO). It acts in a calmodulin-dependent manner, selectively reducing calcium wave frequency in cardiomyocytes only in the presence of calmodulin (Zhao 2020, DOI). Dantrolene has shown in vivo efficacy in pancreatitis models and relevance for neurodegenerative and ischemic disease research. The compound is supplied as a high-purity (>98%) solid, soluble in DMSO but not water or ethanol, and is recommended for short-term solution use. Its applications extend into CRISPR genome editing and synthetic lethality studies, leveraging its unique ability to modulate calcium-dependent signaling pathways (Targeting Ryanodine Receptor Signaling).

    Biological Rationale

    Ryanodine receptors (RyRs) are intracellular calcium release channels located on the endoplasmic and sarcoplasmic reticulum membranes. They regulate calcium homeostasis, which is fundamental for muscle contraction, neuronal excitability, and cell survival (Nature Communications 2025). Dysregulation of RyR-mediated calcium signaling is causally linked to pathological states, including malignant hyperthermia, neurodegenerative diseases, ischemia, hypoxia, and acute pancreatitis. Modulating RyR function enables control of cellular calcium transients, offering a translational research tool for modeling disease processes and evaluating pharmacological interventions.

    Mechanism of Action of Dantrolene, sodium salt

    Dantrolene sodium salt (APExBIO, B6329) is a small-molecule antagonist of RyR channels. It exhibits an IC50 of 5.9 ± 0.3 nM for RyR2 under physiological ionic conditions (pH 7.4, 37°C). The inhibition of RyR activity by dantrolene is strictly calmodulin-dependent; in mouse cardiomyocytes, dantrolene reduced both frequency and amplitude of spontaneous calcium waves only when calmodulin was present (BBA Molecular Basis of Disease). This specificity distinguishes dantrolene from other RyR modulators. The molecular structure—sodium (E)-1-(((5-(4-nitrophenyl)furan-2-yl)methylene)amino)-4-oxo-4,5-dihydro-1H-imidazol-2-olate—confers solubility in DMSO (≥12.2 mg/mL) but not in water or ethanol. Dantrolene's effect is reversible and does not significantly alter resting calcium levels, providing a controlled approach to short-term RyR inhibition in vitro and in vivo.

    Evidence & Benchmarks

    • Dantrolene sodium salt inhibits RyR2 channels with an IC50 of 5.9 ± 0.3 nM (pH 7.4, 37°C) (APExBIO product datasheet).
    • In calmodulin-supplemented mouse cardiomyocytes, dantrolene reduces spontaneous calcium wave frequency and amplitude compared to vehicle (Zhao 2020, DOI).
    • In a mouse model of caerulein-induced pancreatitis, dantrolene treatment suppresses pancreatic trypsin activity and mitigates histological damage (Konno 2019, DOI).
    • Drug-repurposing screens in human iPSCs confirm that dantrolene modulates DNA double-strand break repair pathway outcomes, potentially impacting CRISPR-induced genome editing (Macak et al., Nature Communications 2025).
    • Dantrolene is supplied with >98% purity, with HPLC and NMR quality control, ensuring reproducibility (APExBIO, product page).

    For a broader perspective on ryanodine receptor antagonism in genome editing, see Targeting Ryanodine Receptor Signaling for Precision Modulation in CRISPR Editing. This article specifically details product characteristics, purity, and context for synthetic lethality workflows, extending the translational focus of the linked piece.

    Applications, Limits & Misconceptions

    Applications

    • Calcium signaling research: Dantrolene sodium salt is used to dissect RyR-dependent calcium dynamics in muscle and neuronal cells.
    • CRISPR genome editing: Modulates DNA repair pathway choice by altering intracellular Ca2+ flux during DSB repair (Nature Communications 2025).
    • Pancreatitis and neurodegeneration models: Demonstrated efficacy in reducing cellular damage in murine pancreatitis and proposed for use in neurodegenerative disease models.
    • Synthetic lethality and precision medicine: Enables studies on vulnerability of cancer cells with defective DNA repair genes.

    Common Pitfalls or Misconceptions

    • Ineffective in absence of calmodulin: Dantrolene requires calmodulin for RyR inhibition; no effect is observed in calmodulin-deficient systems (Zhao 2020).
    • Not water/ethanol soluble: Dantrolene sodium salt is insoluble in water and ethanol; use DMSO for stock preparation (APExBIO).
    • Short-term solution stability: Solutions are stable only for short-term use; degradation may occur beyond recommended periods.
    • Not a general calcium channel blocker: Dantrolene specifically targets RyRs and does not inhibit voltage-gated calcium channels.
    • Not suitable for chronic in vivo dosing in some models: Chronic dantrolene exposure can lead to toxicity; dosing regimens must be validated for each application.

    Workflow Integration & Parameters

    Dantrolene sodium salt should be stored at room temperature as a dry solid. For experimental use, dissolve in DMSO to a minimum concentration of 12.2 mg/mL; avoid aqueous or ethanol solvents due to insolubility. Prepare working solutions immediately prior to use to maximize stability and minimize degradation. In cell-based assays, titrate concentrations to match the RyR subtype and cell type used; typical inhibitory concentrations range from 1 to 100 nM. Co-supplementation with calmodulin is necessary for effective RyR inhibition in vitro. Quality control is ensured via HPLC and NMR as per APExBIO lot specifications. For integration into CRISPR workflows, time dantrolene addition to coincide with double-strand break induction (Nature Communications 2025).

    Conclusion & Outlook

    Dantrolene sodium salt (APExBIO, B6329) is a rigorously benchmarked RyR antagonist enabling precise experimental control over calcium signaling in disease and genetic engineering models. Its calmodulin-dependent mechanism and high purity make it a preferred research compound for studies on calcium homeostasis, synthetic lethality, and genome editing. As translational applications of RyR modulation expand, dantrolene remains a critical tool for mechanistic dissection and therapeutic modeling. For comprehensive QC data and ordering, visit the Dantrolene sodium salt product page. For in-depth perspectives on calcium signaling and DNA repair, see the recent synthesis in Targeting Ryanodine Receptor Signaling, which this article updates by adding product-specific workflow guidance and benchmarking.